Abstract |
We have examined the effect of the perfluorocarbon emulsion, Fluosol-DA 20% (FDA), on blood flow in rats bearing an advanced solid Walker 256 tumor implanted s.c. Blood-FDA exchange in unanesthetized rats maintained under 100% oxygen was accomplished by simultaneous arterial withdrawal and i.v. infusion until the hematocrit was less than 4%. Control rats were maintained under 100% oxygen but did not undergo any exchange. Regional blood flow studies in tumors of control and FDA-exchanged rats were performed using [14C] iodoantipyrine and quantitative autoradiography. FDA-blood exchange did not increase flow to the whole tumor. Similarly, the pattern of regional flow within the tumor, which was determined in histologically distinct areas--including dense and normocellular, necrotic and peripheral zones invading into muscle and connective tissue--was not substantially altered. Flow to cerebral tissue was increased two-fold, although flow to normal tissues including temporalis muscle, skin and diaphragm was not altered. These results show that FDA-blood exchange does not enhance vascular flow in solid Walker 256 tumor implanted s.c. in the rat.
|
Authors | P Klubes, S Hiraga, R L Cysyk, E S Owens, R G Blasberg |
Journal | European journal of cancer & clinical oncology
(Eur J Cancer Clin Oncol)
Vol. 23
Issue 12
Pg. 1859-67
(Dec 1987)
ISSN: 0277-5379 [Print] England |
PMID | 3436350
(Publication Type: Journal Article)
|
Chemical References |
- Blood Substitutes
- Drug Combinations
- Fluorocarbons
- Hydroxyethyl Starch Derivatives
- glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination
|
Topics |
- Animals
- Blood Substitutes
(pharmacology)
- Carcinoma 256, Walker
(blood supply)
- Drug Combinations
(pharmacology)
- Fluorocarbons
(pharmacology)
- Hydroxyethyl Starch Derivatives
- Rats
- Regional Blood Flow
(drug effects)
|